Stocks in Focus

Selected for Two Government-Funded Projects… MICUBE SOLUTION, INC. Hits Daily Price Limit [Featured Stock]

Kwon Oh Seok
2026-09-02 09:34:56
[Edaily Reporter Kwon Oh Seok ] MICUBE SOLUTION, INC.(373170)’s stock price has hit the daily upper limit early in the trading session. It appears that buying interest is surging following news that the company has been selected for two government-funded projects.
(Photo courtesy of MICUBE SOLUTION, INC.)

According to MP Doctor on the 2nd, MICUBE SOLUTION, INC.’s stock is trading at 2,210 won as of 9:29 a.m., up 30.00% from the previous trading day.
Earlier today, MICUBE SOLUTION, INC. announced in a regulatory filing that it had been selected for two government-funded projects under the “Project to Foster a Research and Development Ecosystem for Physical AI-Based Software Platforms,” organized by the Ministry of Science and ICT and the National IT Industry Promotion Agency.
The two projects are “Standardization of Collaborative Intelligence Physical AI Software and Design and Construction of a Modular SDF-OCS” and “Development of Physical AI-Digital Twin Virtual Environment Technology.” The research period is a total of 53 months, from August 1, 2026, to December 31, 2030. MICUBE SOLUTION, INC. has been allocated a total of 6.1 billion won in government-funded R&D funding.

Economy

Corporation

IT·Science

Economy

[VC's Pick] LegalTech Firm 'Legora' Expands into Korea, Secures Series E Funding

This week (October 19–23), startups in various sectors—including accommodation solutions, AI video production, and digital healthcare—secured investments from venture capital (VC) firms and accelerato…
2026-10-24 13:07:04

Corporation

“Are All Medications the Same for a Runny Nose and Sneezing?”… The Differences Between Zyrtec, Allegra, and AllerShot [Medicine 101]

During seasonal transitions, when the temperature difference between morning and evening widens, more people complain of sneezing, a clear runny nose, and itchy noses and eyes. While it’s easy to mist…
2026-10-24 08:59:02

IT·Science

Rokit Healthcare Plunges 20% Following FDA Warning Letter to U.S. Partner [K-bio Pulse]

Korean small-cap pharma, biotech, and healthcare stocks moved in opposite directions on Oct. 22, as large-cap chipmakers weakened. Rokit Healthcare posted the steepest decline on the KOSDAQ, while in-…
2026-10-24 06:17:02